Dyadic International/$DYAI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Dyadic International
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
Ticker
$DYAI
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
6
ISIN
US26745T1016
Website
DYAI Metrics
BasicAdvanced
$30M
-
-$0.20
0.90
-
Price and volume
Market cap
$30M
Beta
0.9
52-week high
$2.20
52-week low
$0.91
Average daily volume
42K
Financial strength
Current ratio
3.978
Quick ratio
3.87
Long term debt to equity
542.339
Total debt to equity
548.391
Interest coverage (TTM)
-11.30%
Profitability
Gross margin (TTM)
62.07%
Net profit margin (TTM)
-163.94%
Operating margin (TTM)
-161.86%
Revenue per employee (TTM)
$590,000
Management effectiveness
Return on assets (TTM)
-34.95%
Return on equity (TTM)
-214.26%
Valuation
Price to revenue (TTM)
8.314
Price to book
32.54
Price to tangible book (TTM)
32.54
Price to free cash flow (TTM)
-6.142
Free cash flow yield (TTM)
-16.28%
Free cash flow per share (TTM)
-16.26%
Growth
Revenue change (TTM)
57.59%
Earnings per share change (TTM)
-27.68%
3-year revenue growth (CAGR)
11.10%
10-year revenue growth (CAGR)
2.26%
3-year earnings per share growth (CAGR)
-23.38%
10-year earnings per share growth (CAGR)
3.45%
What the Analysts think about DYAI
Analyst ratings (Buy, Hold, Sell) for Dyadic International stock.
DYAI Financial Performance
Revenues and expenses
DYAI News
AllArticlesVideos
Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications
GlobeNewsWire·4 weeks ago
Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025
GlobeNewsWire·2 months ago
Dyadic to Present at World Vaccine Congress | Washington
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Dyadic International stock?
Dyadic International (DYAI) has a market cap of $30M as of June 30, 2025.
What is the P/E ratio for Dyadic International stock?
The price to earnings (P/E) ratio for Dyadic International (DYAI) stock is 0 as of June 30, 2025.
Does Dyadic International stock pay dividends?
No, Dyadic International (DYAI) stock does not pay dividends to its shareholders as of June 30, 2025.
When is the next Dyadic International dividend payment date?
Dyadic International (DYAI) stock does not pay dividends to its shareholders.
What is the beta indicator for Dyadic International?
Dyadic International (DYAI) has a beta rating of 0.9. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.